Principia SGR

Principia SGR is a prominent Italian venture capital firm dedicated to investing in innovative companies across multiple sectors. With over a decade of experience, the firm manages several funds, including Principia Fund, Principia II, Principia III - Health, and Principia IV - Alis. Principia III - Health is the first Italian venture capital and growth capital fund specifically focused on the healthcare sector, targeting companies with high innovation content, such as start-ups, spin-offs, and SMEs. Principia IV - Alis is the first fund in Italy to specialize in fashion, design, and creativity.

The firm's investment strategy encompasses a broad range of industries, including healthcare, digital industries, fashion, design, and creativity. Principia SGR invests at various stages, from seed to growth, aiming to support companies with high innovation content. The firm has a strong geographical focus on Italy, seeking to foster innovation and growth within the country.

Principia SGR has a track record of supporting innovative companies, such as Enterome Bioscience SA, a company specializing in the microbiome and its role in the immune system within intestinal diseases and cancer. The firm's commitment to innovation and growth is evident in its diverse portfolio and strategic focus on high-potential sectors.